Ultrasound contrast agents: a review.

During the past 25 years, many attempts have been made to establish effective ultrasound contrast agents for both cardiac and noncardiac applications. The ideal ultrasound contrast agent would be: (a) nontoxic; (b) injectable intravenously; (c) capable of passing through the pulmonary, cardiac and capillary circulations; and (d) stable for recirculation. A variety of potential ultrasound contrast agents have been or are now under development. Present and future ultrasound contrast agents should provide for increased diagnostic capabilities in a variety of normal and abnormal vessels and organs throughout the body. These agents will enhance tumor vascularity, delineate areas of ischemia, as well as improve visualization of vascular stenosis. Future developments with modification of ultrasound equipment should increase the capabilities of these agents to improve imaging as well as Doppler sensitivity.

[1]  S. Feinstein,et al.  Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty. , 1986, Journal of the American College of Cardiology.

[2]  H. Feigenbaum,et al.  Identification of Ultrasound Echoes from the Left Ventricle by Use of Intracardiac Injections of Indocyanine Green , 1970, Circulation.

[3]  G. Maurer,et al.  Correlation of myocardial echo contrast disappearance rate ("washout") and severity of experimental coronary stenosis. , 1984, Journal of the American College of Cardiology.

[4]  G. Kino Acoustic waves : devices, imaging, and analog signal processing , 1987 .

[5]  M Halliwell,et al.  Ultrasonic Doppler studies of the breast. , 1982, Ultrasound in medicine & biology.

[6]  S. Feinstein,et al.  Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. , 1987, American heart journal.

[7]  E. Unger,et al.  Cellulose as a gastrointestinal US contrast agent. , 1992, Radiology.

[8]  J. Ophir,et al.  Aqueous solutions as potential ultrasonic contrast agents. , 1979, Ultrasonic imaging.

[9]  R. Schlief,et al.  Improved sensitivity of color Doppler by SH U 454. , 1989, The American journal of cardiology.

[10]  R. Schlief,et al.  Transvaginal hysterosalpingo-contrast-sonography (Hy-Co-Sy) compared with conventional tubal diagnostics. , 1989, Human reproduction.

[11]  T. Takada,et al.  Contrast-enhanced intraoperative ultrasonography of small hepatocellular carcinomas. , 1990, Surgery.

[12]  A. Shmulewitz Ultrasonic multifeature maps of liver based on an amplitude loss technique and a conventional B-scan , 1992, IEEE Transactions on Biomedical Engineering.

[13]  F Forsberg,et al.  Galactose‐based intravenous sonographic contrast agent: experimental studies , 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[14]  R. Gramiak,et al.  Ultrasound cardiography: contrast studies in anatomy and function. , 1969, Radiology.

[15]  D. Carter,et al.  Correlation of Doppler US tumor signals with neovascular morphologic features. , 1988, Radiology.

[16]  S. Tarui,et al.  Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles. , 1993, Radiology.

[17]  R. Schlief,et al.  Hysterosalpingo-contrast sonography of the uterus and fallopian tubes: results of a clinical trial of a new contrast medium in 120 patients. , 1991, Radiology.

[18]  K. Parker,et al.  Ultrasound properties of liver with and without particulate contrast agents. , 1991, Ultrasound in medicine & biology.

[19]  R. Mattrey,et al.  IV injection of air-filled human albumin microspheres to enhance arterial Doppler signal: a preliminary study in rabbits. , 1989, AJR. American journal of roentgenology.

[20]  J. Roelandt,et al.  Quantification of transpulmonary echocontrast effects. , 1993, Ultrasound in medicine & biology.

[21]  S. Kaul,et al.  Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography. , 1986, Journal of the American College of Cardiology.

[22]  K J Parker,et al.  Contrast agents in diagnostic ultrasound. , 1989, Ultrasound in medicine & biology.

[23]  S. Kaul Risk area determination using myocardial contrast echocardiography , 1990 .

[24]  D. Carter,et al.  Tumor vascular signals in renal masses: detection with Doppler US. , 1988, Radiology.

[25]  M. Kudo,et al.  Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. , 1992, Radiology.

[26]  S. Kaul Contrast echocardiography and myocardial perfusion , 1991, Clinical cardiology.

[27]  K Torizuka,et al.  A new method of measuring in vivo sound speed in the reflection mode , 1988, Journal of clinical ultrasound : JCU.

[28]  T. Shawker,et al.  Lipid emulsions as contrast agents for hepatic sonography: an experimental study in rabbits. , 1985, Ultrasonic imaging.

[29]  E. Walach,et al.  Local tissue attenuation images based on pulsed-echo ultrasound scans , 1989, IEEE Transactions on Biomedical Engineering.

[30]  K J Parker,et al.  A particulate contrast agent with potential for ultrasound imaging of liver. , 1987, Ultrasound in medicine & biology.

[31]  A. Weyman,et al.  The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. , 1987, Circulation.

[32]  E. G. Tickner,et al.  Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. , 1980, Investigative radiology.

[33]  V L Newhouse,et al.  Second harmonic ultrasonic blood perfusion measurement. , 1993, Ultrasound in medicine & biology.

[34]  N de Jong,et al.  Ultrasound scattering properties of Albunex microspheres. , 1993, Ultrasonics.

[35]  C. McKay,et al.  Accuracy of evaluation of the presence and severity of aortic and mitral regurgitation by contrast 2-dimensional echocardiography. , 1983, The American journal of cardiology.

[36]  D. Miller Neurologic complications of petrosal sinus sampling. , 1992, Radiology.

[37]  Echocontrast agent enhanced color flow imaging of the breast , 1993, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[38]  Success of myocardial contrast echocardiography by peripheral venous injection method : Visualization of area at risk , 1993 .

[39]  P. Wells Biomedical Ultrasonics , 1977 .

[40]  B B Gosink,et al.  Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. , 1982, Radiology.

[41]  J. Elion,et al.  Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. , 1989, Journal of the American College of Cardiology.

[42]  J. Ophir,et al.  In Vivo Enhancement of Ultrasonic Image Luminance by Aqueous Solutions with High Speed of Sound , 1981 .

[43]  John M. Reid,et al.  Scattering of Ultrasound by Blood , 1976, IEEE Transactions on Biomedical Engineering.

[44]  D. Sahn,et al.  Ultrasonic contrast studies for the detection of cardiac shunts. , 1984, Journal of the American College of Cardiology.

[45]  F Forsberg,et al.  Artifacts in ultrasonic contrast agent studies. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[46]  M. Schlepper,et al.  Echocardiographic imaging of the left ventricle by peripheral intravenous injection of echo contrast agent. , 1988, American heart journal.

[47]  J M Thijssen,et al.  A general model for the absorption of ultrasound by biological tissues and experimental verification. , 1986, The Journal of the Acoustical Society of America.

[48]  A. Weyman,et al.  Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain and kidney. , 1985, Journal of the American College of Cardiology.

[49]  B B Goldberg,et al.  Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. , 1990, Radiology.

[50]  K. Schwarz,et al.  Sonication of echo-contrast agents: a standardized and reproductible method , 1988 .

[51]  I Céspedes,et al.  On the feasibility of pulse-echo speed of sound estimation in small regions: simulation studies. , 1992, Ultrasound in medicine & biology.

[52]  K. Shung,et al.  On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion. , 1990, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[53]  K. Shung,et al.  Ultrasonic characterization of AlbunexR, a new contrast agent , 1990 .

[54]  R. Schlief,et al.  Successful Opacification of the Left Heart Chambers on Echocardiographic Examination after Intravenous Injection of a New Saccharide Based Contrast Agent , 1990, Echocardiography.

[55]  R. Schlief,et al.  Blood‐Pool Enhancement with SH U 508 A: Results of Phase II Clinical Trials , 1991, Investigative radiology.

[56]  S. Savader,et al.  US-guided pseudoaneurysm repair with a compression device. , 1993, Radiology.

[57]  Kevin J. Parker,et al.  Quantitative Tissue Characterzation Based on Pulsed-Echo Ultrasound Scans , 1986, IEEE Transactions on Biomedical Engineering.

[58]  B B Gosink,et al.  Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results. , 1987, Radiology.

[59]  B. Goldberg Ultrasonic cholangiography. Gray-scale B-scan evaluation of the common bile duct. , 1976, Radiology.

[60]  S. Powsner,et al.  Automated production and analysis of echo contrast agents. , 1986, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[61]  J. D’Arrigo,et al.  Lipid-coated ultrastable microbubbles as a contrast agent in neurosonography. , 1990, Investigative radiology.

[62]  Walter G. Mayer,et al.  A course of lectures on the theory of sound , 1965 .

[63]  V. Newhouse,et al.  The Detection of Blood Impurities Using Ultrasound Doppler , 1980 .

[64]  R Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[65]  F J Ten Cate,et al.  Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. , 1984, Journal of the American College of Cardiology.

[66]  S. Kaul Quantitation of myocardial perfusion with contrast echocardiography. , 1991, American journal of cardiac imaging.

[67]  M. André,et al.  Enhancement of the echogenicity of flowing blood by the contrast agent perflubron. , 1993, Investigative radiology.

[68]  R. Bing,et al.  Microbubble dynamics visualized in the intact capillary circulation. , 1984, Journal of the American College of Cardiology.

[69]  V. Newhouse,et al.  Simulated Capillary Blood Flow Measurement Using a Nonlinear Ultrasonic Contrast Agent1 , 1992 .

[70]  K. Parker,et al.  Ultrasound contrast for hepatic tumors using IDE particles. , 1990, Investigative radiology.

[71]  M. Ziskin,et al.  Contrast agents for diagnostic ultrasound. , 1972, Investigative radiology.

[72]  D. Uphoff,et al.  Applications of lipid-coated microbubble ultrasonic contrast to tumor therapy. , 1993, Ultrasound in medicine & biology.

[73]  R. Kuc Bounds on estimating the acoustic attenuation of small tissue regions from reflected ultrasound , 1985, Proceedings of the IEEE.

[74]  S. Powsner,et al.  Contrast ultrasonography of the kidney: a new method for evaluation of renal perfusion in vivo. , 1987, Circulation.

[75]  J. Ophir,et al.  On the Frequency Dependence of Attenuation in Normal and Fatty Liver , 1983, IEEE Transactions on Sonics and Ultrasonics.

[76]  J. Siegert,et al.  Preclinical and clinical results with an ultrasonic contrast agent. , 1988 .

[77]  N de Jong,et al.  Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements. , 1992, Ultrasonics.

[78]  M. Kudo,et al.  Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. , 1992, AJR. American journal of roentgenology.

[79]  R. Kerber,et al.  Use of an ultrasonic contrast method in the diagnosis of valvular regurgitation and intracardiac shunts. , 1974, The American journal of cardiology.

[80]  J. Ophir,et al.  Ultrasonic Backscatter from Contrast Producing Collagen Microspheres1 , 1980 .

[81]  R. Mattrey,et al.  Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging. , 1989, AJR. American journal of roentgenology.

[82]  D D Watson,et al.  Assessment of Regional Myocardial Blood Flow with Myocardial Contrast Two-dimensional Echocardiography , 1989, Journal of the American College of Cardiology.

[83]  J. D’Arrigo,et al.  Lipid‐Coated Uniform Microbubbles for Earlier Sonographic Detection of Brain Tumors , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[84]  S. Kaul,et al.  Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[85]  K. Schwarz,et al.  Quantitative echo contrast concentration measurement by Doppler sonography. , 1993, Ultrasound in medicine & biology.

[86]  M Halliwell,et al.  Tumour detection by ultrasonic Doppler blood-flow signals. , 1977, Ultrasonics.

[87]  E. Unger,et al.  Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. , 1992, Radiology.

[88]  G M Pohost,et al.  Contrast echocardiography in acute myocardial ischemia: I. In vivo determination of total left ventricular "area at risk". , 1984, Journal of the American College of Cardiology.

[89]  B. Goldberg Ultrasonic measurement of the aortic arch, right pulmonary artery, and left atrium. , 1971, Radiology.